Sanofi India gains after reporting decent Q2 results

Sanofi India gained 2.63% to Rs 4,617.90 at 12:55 IST on BSE after net profit rose 32.9% to Rs 85.30 crore on 11.6% rise in total income to Rs 624.40 crore in Q2 June 2016 over Q2 June 2015.

The result was announced after market hours on Friday, 22 July 2016.

Meanwhile, the BSE Sensex was up 133.11 points, or 0.48%, to 27,936.35

On BSE, so far 1,039 shares were traded in the counter, compared with an average volume of 2,728 shares in the past one quarter. The stock hit a high of Rs 4,650 and a low of Rs 4,586 so far during the day. The stock had hit a record high of Rs 4,770 on 4 July 2016. The stock had hit a 52-week low of Rs 3,616 on 23 July 2015. The stock had outperformed the market over the past one month till 22 July 2016, rising 8.19% compared with Sensex's 3.88% rise. The scrip, however, underperformed the market in past one quarter, advancing 6.94% as against Sensex's 7.61% rise.

The large-cap pharma company has equity capital of Rs 23.03 crore. Face value per share is Rs 10.

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. In India, Sanofi operates through four entities - Sanofi India, Sanofi-Synthelabo (India), Sanofi Pasteur India, and Shantha Biotechnics.

Powered by Capital Market - Live News